亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure

危险分层 医学 期限(时间) 内科学 疾病 重症监护医学 量子力学 物理
作者
Georg Semmler,Sonia Alonso López,Mònica Pons,Sabela Lens,Elton Dajti,Marie Griemsmann,Alberto Zanetto,Lukas Burghart,Stefanie Hametner‐Schreil,Lukas Hartl,Marisa Manzano,Sergio Rodríguez‐Tajes,Paola Zanaga,Michael Schwarz,María Luisa Gutiérrez García,Mathias Jachs,Anna Pocurull,Benjamín Polo Lorduy,Dominik Ecker,Beatriz Mateos
出处
期刊:Hepatology [Lippincott Williams & Wilkins]
卷期号:81 (2): 609-624 被引量:20
标识
DOI:10.1097/hep.0000000000001005
摘要

BACKGROUND AND AIMS: Around 750,000 patients per year will be cured of HCV infection until 2030. Those with compensated advanced chronic liver disease remain at risk for hepatic decompensation and de novo HCC. Algorithms have been developed to stratify risk early after cure; however, data on long-term outcomes and the prognostic utility of these risk stratification algorithms at later time points are lacking. APPROACH AND RESULTS: We retrospectively analyzed a cohort of 2335 patients with compensated advanced chronic liver disease (liver stiffness measurement≥10 kPa) who achieved HCV-cure by interferon-free therapies from 15 European centers (median age 60.2±11.9 y, 21.1% obesity, 21.2% diabetes).During a median follow-up of 6 years, first hepatic decompensation occurred in 84 patients (3.6%, incidence rate: 0.74%/y, cumulative incidence at 6 y: 3.2%); 183 (7.8%) patients developed de novo HCC (incidence rate: 1.60%/y, cumulative incidence at 6 y: 8.3%), with both risks being strictly linear over time.Baveno VII criteria to exclude (FU-liver stiffness measurement <12 kPa and follow-up platelet count >150 g/L) or rule-in (FU-liver stiffness measurement ≥25 kPa) clinically significant portal hypertension (CSPH) stratified the risk of hepatic decompensation with proportional hazards. Estimated probability of CSPH discriminated patients developing versus not developing hepatic decompensation in the gray zone (ie, patients meeting none of the above criteria).Published HCC risk stratification algorithms identified high-incidence and low-incidence groups; however, the size of the latter group varied substantially (9.9%-69.1%). A granular "HCC-sustained virologic response" model was developed to inform an individual patient's HCC risk after HCV-cure. CONCLUSIONS: In patients with compensated advanced chronic liver disease, the risks of hepatic decompensation and HCC remain constant after HCV-cure, even in the long term (>3 y). One-time post-treatment risk stratification based on noninvasive criteria provides important prognostic information that is maintained during long-term follow-up, as the hazards remain proportional over time.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
微笑南烟发布了新的文献求助10
3秒前
7秒前
幸福的沛萍完成签到,获得积分10
8秒前
微笑南烟完成签到,获得积分10
13秒前
ppp发布了新的文献求助10
17秒前
曲聋五完成签到 ,获得积分0
23秒前
初景的应助被是磊啊采纳,获得20
23秒前
Ballyhooed完成签到,获得积分10
25秒前
26秒前
嘻嘻哈哈的应助被Minnie采纳,获得10
27秒前
康子浩发布了新的文献求助10
29秒前
英俊大树发布了新的文献求助10
32秒前
暖暖发布了新的文献求助10
32秒前
34秒前
36秒前
36秒前
虚心的迎彤完成签到,获得积分10
36秒前
38秒前
雪山大地发布了新的文献求助10
39秒前
Zhou完成签到 ,获得积分10
39秒前
英俊大树完成签到,获得积分10
39秒前
和谐以冬发布了新的文献求助10
40秒前
研友_VZG7GZ的应助被暖暖采纳,获得10
41秒前
CodeCraft的应助被王艳采纳,获得10
44秒前
histamin完成签到,获得积分10
47秒前
49秒前
52秒前
Collice发布了新的文献求助30
57秒前
杏仁核发布了新的文献求助10
58秒前
充电宝的应助被康子浩采纳,获得10
58秒前
ppp发布了新的文献求助10
59秒前
桃里里完成签到,获得积分10
1分钟前
1分钟前
1分钟前
废纸箱发布了新的文献求助10
1分钟前
Minnie完成签到,获得积分10
1分钟前
1分钟前
杏仁核完成签到,获得积分10
1分钟前
沧海君发布了新的文献求助10
1分钟前
JamesPei的应助被废纸箱采纳,获得10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8165939
求助须知:如何正确求助?哪些是违规求助? 9559318
关于积分的说明 21749898
捐赠科研通 7756692
什么是DOI,文献DOI怎么找? 3429083
关于科研通互助平台的介绍 2553385
邀请新用户注册赠送积分活动 2473623